Food and drug interactions with monoamine oxidase inhibitors (MAOIs) can lead to serious adverse effects, including hypertensive crisis and serotonin syndrome. Newer MAOIs that are selective and reversible or that have non-oral delivery methods may lower these risks and, thus, make MAOIs a possible choice of treatment for patients with depression.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders
Save
Cite